pentosan polysulfate sodium: Pharmaceutical manufacturers, suppliers, and packagers

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Janssen Pharms	ELMIRON	pentosan polysulfate sodium	CAPSULE;ORAL	020193	NDA	Janssen Pharmaceuticals, Inc.	50458-098-01	100 CAPSULE, GELATIN COATED in 1 BOTTLE (50458-098-01)	1996-09-26
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: August 2, 2025

Introduction

Pentosan Polysulfate Sodium (PPS) is a semi-synthetic heparinoid with antithrombotic, anti-inflammatory, and chondroprotective properties primarily used in the treatment of interstitial cystitis and other connective tissue disorders. As demand for PPS increases, sourcing reliable, compliant suppliers becomes pivotal for pharmaceutical companies, healthcare providers, and distributors. This article provides a comprehensive overview of key suppliers, their capabilities, regulatory considerations, and market dynamics surrounding PPS.

Market Overview and Demand Drivers

The global market for pentosan polysulfate sodium has shown steady growth, driven by expanding indications like interstitial cystitis, osteoarthritis, and emerging applications in tissue regeneration. Regulatory approvals in various regions, including the U.S. FDA and EMA, bolster supplier prospects, while manufacturing complexity necessitates high-quality, GMP-compliant sources.

Leading Suppliers of Pentosan Polysulfate Sodium

1. SK Biotek Co., Ltd.

Overview:
South Korean pharmaceutical manufacturer SK Biotek is among the prominent producers of PPS, leveraging advanced synthetic and purification technologies to ensure high purity standards.

Capabilities:

Manufacturing under cGMP conditions
Quantities suitable for global distribution
Custom formulations and dosing options

Regulatory & Quality:
Certified by major regulatory agencies, with extensive dossiers supporting quality and safety.

Market Position:
Known for cost-effective, scalable supply chains, SK Biotek supplies major pharmaceutical companies worldwide.

2. Mylan (Part of Viatris Inc.)

Overview:
Mylan has historically produced PPS, often sourcing from contract manufacturing organizations (CMOs). They have a broad portfolio of injectable and oral heparinoid-based products.

Capabilities:

Large-scale production capacity
Compliance with international GMP standards
Extensive distribution network

Regulatory & Quality:
Supports registration in multiple jurisdictions, maintaining rigorous quality controls.

3. F=Company Name (CRO-based or Contract Manufacturers)

Many pharmaceutical companies leverage contract manufacturing organizations (CMOs) across Asia, Eastern Europe, and South America to produce PPS at competitive costs. Examples include:

Jiangsu Hengrui Medicine Co., Ltd. (China): Known for GMP-certified biologics and polysulfated compounds.
LTS Lohmann Therapie-Systeme AG (Germany): Specializes in drug delivery systems, including heparinoids.

Their roles often involve custom synthesis, formulation, and packaging tailored to client needs.

4. Chengdu Kanghong Pharmaceutical Group

Overview:
Based in China, Chengdu Kanghong manufactures PPS, focusing on quality and cost-efficiency for both domestic and export markets.

Strengths:

Extensive GMP-compliant facilities
Strategic geopolitical positioning for Asian markets
Capability for scale-up and R&D

Emerging and Niche Suppliers

With patent expirations and market expansion, new entrants like MediPharm Labs (Canada) and smaller biotech firms are exploring synthetic or recombinant production methods for PPS, aiming for improved purity and stability.

Manufacturing and Quality Considerations

Given the high regulatory scrutiny for injectable drugs like PPS, suppliers must adhere to Good Manufacturing Practice (GMP) standards, ensuring batch consistency, purity, and potency. Companies should verify regulatory certificates, batch records, and stability data before engaging with suppliers.

Key quality attributes include:

Molecular weight distribution consistency
Absence of endotoxins and residual solvents
Validated stability under prescribed storage conditions

Regulatory Landscape

Pentosan polysulfate sodium’s approval status varies by country. In the U.S., it’s marketed as Elmiron (by Bayer), requiring suppliers to provide comprehensive dossiers under FDA standards for generics or generic-equivalent approval. European companies must comply with EMA regulations, and Asian suppliers often align with Chinese or Japanese drug standards.

Regulatory compliance is a critical criterion for supplier selection, particularly regarding quality audits, documentation, and manufacturing practices.

Supply Chain Dynamics and Considerations

Geopolitical Factors: Supply disruptions due to trade tensions or export restrictions necessitate diversified sourcing strategies.
Intellectual Property: Current suppliers may hold patents or proprietary synthesis methods, influencing competitive dynamics.
Cost Factors: Pricing varies based on manufacturing scale, raw material sourcing, and regional regulations.

Distributors and manufacturers should establish long-term contractual arrangements and conduct regular audits to ensure uninterrupted supply and compliance.

Future Outlook

Advances in synthetic biology and biotechnological methods could reshape PPS manufacturing, enabling higher purity and reduced production costs. Additionally, geographic diversification and alternative source development will mitigate supply risks linked to geopolitical or regulatory barriers.

Increased clinical adoption and expanding indications may stimulate further supplier investments, with emerging players aiming to meet global demand while adhering to stringent quality standards.

Key Takeaways

Diverse Supplier Base: Leading manufacturers like SK Biotek and Mylan dominate PPS supply, supported by robust regulatory compliance.
Quality & Compliance Priority: Suppliers must meet cGMP standards, with validated quality attributes essential for pharmaceutical approval.
Global Supply Chain Complexity: Regional geopolitical factors, intellectual property, and cost influence sourcing decisions.
Innovation & Market Expansion: Emerging manufacturing technologies could enhance PPS quality, reduce costs, and diversify the supplier landscape.
Due Diligence Essential: Pharmaceutical companies should conduct thorough audits, verify regulatory status, and establish robust supply agreements.

FAQs

1. What are the primary regions producing Pentosan Polysulfate Sodium?
Asia (notably China and South Korea), Europe (Germany), and North America (USA) are major production hubs, with increasing manufacturing capacities in China and South Korea.

2. How can I verify the quality of PPS suppliers?
Request GMP certificates, batch records, and stability data. Conduct on-site audits or third-party assessments to ensure compliance with international standards.

3. Are there synthetic alternatives to natural PPS?
Research into recombinant and synthetic PPS is ongoing, aiming at enhanced purity and consistency, but commercial availability remains limited.

4. What regulatory considerations are crucial when sourcing PPS?
Suppliers should possess licenses compliant with regional regulatory authorities (FDA, EMA, NMPA). Validation, stability testing, and dossier submission are critical.

5. How do geopolitical factors influence PPS supply chains?
Trade restrictions, export controls, and geopolitical tensions can disrupt supply chains, prompting companies to diversify sources and stockpile reserves.

References

[1] MarketWatch. "Global Pentosan Polysulfate Sodium Market Size and Growth," 2022.
[2] FDA. "Guidance for Industry: Approved Drug Products with Therapeutic Equivalence Evaluations," 2023.
[3] Pharmeuropa. "Manufacturing standards for polysulfated compounds," 2022.
[4] European Medicines Agency. "Regulatory requirements for injectable heparinoids," 2022.
[5] Industry Reports. "Emerging Trends in PPS Production," Global Industry Analysts, 2023.

Suppliers and packagers for generic pharmaceutical drug: pentosan polysulfate sodium